Transforming Pharma's Commercial Capabilities to Drive Maximum Value
Executive SummaryLarge pharmaceutical companies need to accelerate their changing competitive strategies, commercial capabilities, and organizational models to respond adequately to new market conditions. To maximize the value of products, consulting firm Booz Allen proposes aligning commercial operations along three distinct businesses, which cut across specialty and primary care segmentation and which are differentiated based on competitive strategies.
You may also be interested in...
GNC hires Josh Burris as chief US officer; Clasado BioSciences adds Bellchambers as commercial director; and Barentz plans expansion with Cinven investment.